Scott D. Grimes - May 7, 2021 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role
Director
Signature
/s/ Kirk Somers, Attorney-in-Fact
Stock symbol
CDLX
Transactions as of
May 7, 2021
Transactions value $
-$540,971
Form type
4
Date filed
5/11/2021, 04:15 PM
Next filing
May 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction CDLX Common Stock -Sell -$80,465 -802 -0.32% $100.33 249,025 May 7, 2021 Direct F1, F2
transaction CDLX Common Stock -Sell -$131,430 -1,300 -0.52% $101.10 247,725 May 7, 2021 Direct F1, F3
transaction CDLX Common Stock -Sell -$184,230 -1,800 -0.73% $102.35 245,925 May 7, 2021 Direct F1, F4
transaction CDLX Common Stock -Sell -$128,874 -1,243 -0.51% $103.68 244,682 May 7, 2021 Direct F1, F5
transaction CDLX Common Stock -Sell -$15,972 -152 -0.06% $105.08 244,530 May 7, 2021 Direct F1, F6
holding CDLX Common Stock 83,112 May 7, 2021 See Footnote F7

Explanation of Responses:

Id Content
F1 Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on April 1, 2021.
F2 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $99.81 to $100.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2), (3), (4), (5) and (6) to this Form 4.
F3 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $100.82 to $101.63, inclusive.
F4 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $101.90 to $102.83, inclusive.
F5 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $103.185 to $104.14, inclusive.
F6 The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $104.94 to $105.22, inclusive.
F7 The reportable securities are held by the 2013 Scott Grimes GRAT UAD (the "GRAT").